# The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

> **NCT00485394** · PHASE2 · UNKNOWN · sponsor: **Othera Pharmaceuticals** · enrollment: 198 (estimated)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** OT-551
- **DRUG:** OT-551
- **DRUG:** vehicle placebo

## Key facts

- **NCT ID:** NCT00485394
- **Lead sponsor:** Othera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** 2010-02
- **Final completion:** —
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2008-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00485394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00485394, "The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00485394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*